Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Monogenic diabetes resulting from mutations that primarily reduce beta-cell function accounts for 1-2% of diabetes cases, although it is often misdiagnosed as either type 1 or type 2 diabetes. Knowledge of the genetic etiology of diabetes enables more-appropriate treatment, better prediction of disease progression, screening of family members and genetic counseling. We propose that the old clinical classifications of maturity-onset diabetes of the young and neonatal diabetes are obsolete and that specific genetic etiologies should be sought in four broad clinical situations because of their specific treatment implications. Firstly, diabetes diagnosed before 6 months of age frequently results from mutation of genes that encode Kir6.2 (ATP-sensitive inward rectifier potassium channel) or sulfonylurea receptor 1 subunits of an ATP-sensitive potassium channel, and improved glycemic control can be achieved by treatment with high-dose sulfonylureas rather than insulin. Secondly, patients with stable, mild fasting hyperglycemia detected particularly when they are young could have a glucokinase mutation and might not require specific treatment. Thirdly, individuals with familial, young-onset diabetes that does not fit with either type 1 or type 2 diabetes might have mutations in the transcription factors HNF-1alpha (hepatocyte nuclear factor 1-alpha) or HNF-4alpha, and can be treated with low-dose sulfonylureas. Finally, extrapancreatic features, such as renal disease (caused by muta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, an exception is the mutational analyses established for classification of diabetes in the neonate (381-384) as well as in young individuals with a dominant family history of diabetes, often referred to as maturityonset diabetes of the young (MODY) (384,385) (Table 8).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [383]
In the citing paper
“Infants with neonatal diabetes due to a mutation in the KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11; also known as KIR6.2) gene may be treated with sulfonylurea rather than with insulin (258,259).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
In the citing paper
“Genetic markers are currently of limited clinical value in evaluating and managing patients with diabetes; however, mutational analysis is rapidly emerging for classifying diabetes in the neonate (258-260) and in young patients with a dominant family history of diabetes, often referred to as “maturityonset diabetes of the young” (MODY) (261).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
Citations
Cites
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Goto, Y.-I., Nonaka, I., & Horai, S. (1990) · Nature · doi:10.1038/348651a0 · Cited by 2,070
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationChatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“Currently, insulin remains the most common treatment during pregnancy for this patient group, but further studies are required to validate the safety and efficacy of sulfonylureas such as glibenclamide (also known as glyburide) that have least permeability through the placenta and have been used in gestational diabetes”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735 · cited 1×
“Most of those without diabetes have impaired fasting glucose levels”
Background
Research works printed but not linked: 1
- Pearson E et al. (2003) HDL-cholesterol: differentiating between HNF-1α MODY and type 2 diabetes [abstract]. Diabet Med 20 (Suppl 2): S1–S33
Cited by
Items 401–500 of 500
Shepherd, M. H. (2008) · Primary care diabetes · doi:10.1016/j.pcd.2008.02.002 · Cited by 1
Diabète de type 2 associé à des malformations rénales et pancréatiques
Berre, J.-P. L., Bellanné‐Chantelot, C., Bordier, L., Garcia, C., Dupuy, O., Mayaudon, H., & Bauduceau, B. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.04.008 · Cited by 1
Chakraborty, P. P., Patra, S., Biswas, S. N., & Barman, H. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-223723 · Cited by 1
Neonatal diabetes mellitus due to a rare mutation in KCNJ11 gene
Kumar, S., & Thakur, A. (2018) · Indian Journal of Child Health · doi:10.32677/ijch.2018.v05.i11.013 · Cited by 1
Phenotype of a transient neonatal diabetes point mutation (SUR1-R1183W) in mice
Sachse, G., Haythorne, E., Proks, P., Stewart, M. E., Cater, H. L., Ellard, S., Davies, B., & Ashcroft, F. M. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15529.2 · Cited by 2
Self-citationMonogener Diabetes - die Kunst ist das Erkennen
Kapellen, T. M. (2020) · Info Diabetologie · doi:10.1007/s15034-020-2158-2 · Cited by 1
HNF1A-MODY Mutations in Nuclear Localization Signal Impair HNF1A-Import Receptor KPNA6 Interactions
Asaad, F., Korulu, Ş., Özbil, M., & Çapan, Ö. Y. (2021) · The Protein Journal · doi:10.1007/s10930-020-09959-0 · Cited by 1
“Maturity Onset Diabetes of the Young (MODY) is an autosomal dominant inherited disease characterized by asymptomatic hyperglycemia in non-obese young patients and caused by pancreatic beta-cells dysfunction [1].”
BackgroundClinical Characteristics and Gene Mutations of Two Families with MODY 3 in Inner Mongolia
Ren, X.-Y., Xue, M.-R., Yan, Z.-L., Zhang, S., Liu, M., & Li, A.-Z. (2022) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s371141 · Cited by 1
“The most frequent monogenic diabetes type is the maturity onset diabetes of the young (MODY), seen in 1–2% of overall diabetes patients and including a number of single gene disorders which effect pancreatic beta-cell functions.(1) It was first described by Tattersall and Fajans in 1973.”
BackgroundPatel, K. A., Kettunen, J. L. T., Laakso, M., Stančáková, A., Laver, T. W., Colclough, K., Johnson, M. B., Abramowicz, M., Groop, L., Miettinen, P. J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/101881 · Cited by 1
“Age at diagnosis (years), median (IQR), n=13 36 (21-41)”
BackgroundSelf-citationAmbler, G. R., Cameron, F. J., Joshi, K., & Wherrett, D. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch15 · Cited by 1
Molnes, J. (2012) · NORA - Norwegian Open Research Archives
Heritability of type 2 diabetes and related traits
Lehtovirta, M. (2014) · Helda - University of Helsinki Institutional Repository
Monogenic diabetes and pancreatic exocrine dysfunction in mouse and man
Vesterhus, M. N. (2009) · NORA - Norwegian Open Research Archives
Garabeli, A. A. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Diabetes mellitus in Adults - Aspects of Incidence, Autoimmunity and C-peptide
Thunander, M. (2011) · Lund University Publications (Lund University)
Management of Maturity-Onset Diabetes of the Young (MODY)
Botero, D. (2009) · IATREIA · doi:10.17533/udea.iatreia.4543
Search for molecular and metabolic mechanisms contributing to impaired β-cell function
Malmgren, S. (2012) · Lund University Publications (Lund University)
UM OLHAR SOBRE O DIABETES NA INFÂNCIA E NA JUVENTUDE: NEM TODOS SÃO TIPO 1
Anghebem-Oliveira, M. I. (2013) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v25.e4.a2013.pp206-214
“A sulfoniluréia é um medicamento efetivo no controle inicial da hiperglicemia de pacientes com essa mutação, reduzindo a transcrição funcional deste fator no metabolismo da glicose, através da estimulação de insulina pela ativação de ATP e os canais de potássio (22;38).”
BackgroundCukrzyca typu HNF1A MODY u 14-letniej dziewczynki z otyłością
Jakubek‐Kipa, K., Lisowicz, L., Klupa, T., & Mazur, A. (2014) · Pediatria Polska · doi:10.1016/j.pepo.2014.08.001
Managing non-ketotic childhood hyperglycemia
Shivane, V. K., Lila, A. M., Bandgar, T., & Shah, N. (2011) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.90073
Epigenetics for Biomedical Sciences
Hirosawa, M., Lim, H. W., Yagi, S., & Shiota, K. (2009) · Cornea · doi:10.1097/ico.0b013e3181ae96bf
Wolcott-Rallison Syndrome : A Case Report
Alawneh, H. (2014) · Journal of the Royal Medical Services · doi:10.12816/0005532
“(6) Table I(7) illustrates, and compares genetic causes of neonatal diabetes and their associated clinical features.”
Pramfalk, C. (2009) · Figshare
Arteriovascular Calcification Leading to Diagnosis of Maturity-Onset Diabetes of the Young Type 3
Quintos, J. B., Pingul, M. M., & Boney, C. M. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.03.005
“MODY is a monogenic form of diabetes with autosomal dominant inheritance, early age of onset, and a primary defect in beta-cell function.(2) Heterozygousmutations in human hepatocyte nuclear factor 1a (MODY type 3) lead to progressive b-cell dysfunction and diabetes between 10 and 30 years of age.”
BackgroundClinical Utility of Next-Generation Sequencing for The Molecular Diagnosis of Monogenic Diabetes
Johnson, A. K., & del Gaudio, D. (2014) · Personalized Medicine · doi:10.2217/pme.13.111
Caetano, L. A., Jorge, A. A. L., Malaquias, A. C., Trarbach, E. B., Queiroz, M. S., Nery, M., & Teles, M. G. (2012)
Epidemiologie, classificatie en diagnostiek van diabetes bij kinderen en adolescenten
Simm, D. (2015) · Tijdschrift voor kindergeneeskunde · doi:10.1007/s12456-015-0005-5
DellaManna, T., Dias-da-Silva, M. R., Roberto, A., Kunii, I. S., Rolim, A. L., Furuzawa, G. K., Reis, A. F., & de Medicina, E. P. (2012)
Monogenic diabetes – an unappreciated problem among physicians
Niechciał, E., Skowrońska, B., Gertig-Kolasa, A., Krzyśko-Pieczka, I., & Fichna, P. (2014) · Journal of Medical Science · doi:10.20883/medical.e57
Diagnóstico molecular na prática clínica: visão do endocrinologista
Ferraz‐de‐Souza, B. (2015) · Revista de Medicina · doi:10.11606/issn.1679-9836.v94i4p201-210
Endokrinologische Indikationen zur Gendiagnostik
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-47480-8_15
Genetische Diagnostik des MODY Maturity Onset Diabetes of the Young
Bedeutung, K. (2015)
Bacon, S., Kyithar, M. P., McCarthy, A., Burke, M., & Byrne, M. M. (2015) · Endocrine Abstracts · doi:10.1530/endoabs.37.ep355
Wolfsdorf, J. I., & Sperling, M. A. (2012)
Hyperemic iris vessels with uveitis.
Harris, S. L., & Magnus, D. E. (1984) · PubMed
Herbach, N., Aigner, B., & Wanke, R. (2010)
Insights from Monogenic Diabetes
Njølstad, T. S., Ellard, S., & Njølstad, P. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_10
Self-citationEpidemiology and pathogenesis of type 1 diabetes
Parthasarathy, S., & Choudhary, P. (2015) · Wiley eBooks · doi:10.1002/9781119121725.ch7
Not Autoimmune Diabetes Mellitus in Paediatrics
Iafusco, D., Confetto, S., Zanfardino, A., Piscopo, A., Casaburo, F., Cocca, A., Caredda, E., Pezzino, G., Tinto, N., Pirozzi, D., et al. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_12
Clinical Implications of Pharmacogenetic Data
Chiara, G. (2012)
Gravdal, A. (2016) · NORA - Norwegian Open Research Archives
Laser biostimulation of salivary glands in diabetic rats
El-Sadek, H. A., El-Hadidi, S. M. A., Aboul-Ezz, E. H. A., Ibrahim, T., El-Zoghaby, S., Zaky, S., & Abdelgawad, L. M. (2017) · Middle East Journal of Medical Genetics · doi:10.1097/01.mxe.0000511298.93538.a2
“Knowledge of the genetic etiology of diabetes allows proper treatment and improves prediction of disease progression (Murphy et al., 2008).”
BackgroundNext-Generation Sequencing for the Diagnosis of Monogenic Disorders of Insulin Secretion
Johnson, A. E. K., Greeley, S. A. W., & del Gaudio, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-56418-0_11
Stem Cell Therapy for Type-1 Diabetes Mellitus
Thakkar, U. G., Vanikar, A. V., & Trivedi, H. L. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-55687-1_2
Tests aiding diagnosis of monogenic diabetes
Shepherd, M. H., Colclough, K., & McDonald, T. J. (2017) · Practical Diabetes · doi:10.1002/pdi.2122
“family member, ii) autosomal dominant inheritance (with diabetes in a parent or child) and iii) noninsulin dependent diabetes (or evidence of significant endogenous insulin production more than three years post diagnosis) (8).”
BackgroundMODY: one of the most easily missed causes of diabetes
Morris, J., & Morris, D. (2017) · Independent Nurse · doi:10.12968/indn.2017.11.13 · Cited by 3
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_6-1
Transient neonatal diabetes mellitus caused by a novel mutation in the ABCC8 gene
Ünal, E., Yıldırım, R., Taş, F. F., Yıldız, S., Demir, V., & Haspolat, Y. K. (2019) · Journal of Surgery and Medicine · doi:10.28982/josam.515839
“diabetes mellitus at a later period, remit later and have recurrence earlier [3,7].”
BackgroundImproving patient care in monogenic diabetes through research and education
Shepherd, M. H. (2019) · Practical Diabetes · doi:10.1002/pdi.2223
“Practical Diabetes 2019; 36(3): 97–101”
Ein Gestationsdiabetes, der keiner war
Stupin, J. H. (2019) · Info Diabetologie · doi:10.1007/s15034-019-1564-9
Knevel, R., le Cessie, S., Terao, C. C., Slowikowski, K., Cui, J., Huizinga, T. W. J., Costenbader, K. H., Liao, K. P., Karlson, E. W., & Raychaudhuri, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/813220
“Without signs or symptoms, these data may not be particularly informative for most complex rheumatic diseases since these diseases tend to be rare(4-11).”
BackgroundMICROORGANISMS ASSOCIATED WITH DIABETIC FOOT ULCERS
Hassanin, K., Ahmed, E. A., Al-Mokhtar, M., & Yousef, H. F. (2019) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2019.62203
Importance of clinical variables in the diagnosis of MODY2 and MODY3
Corrales, P. J. P., López-Garrido, M.-P., Rubio, L. L., Rodríguez, S. A., Jiménez, L. M. L., Lamas, C., García, J. J. L., Martínez, J. J. A., López, A. H., Castillo, R. R., et al. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.001
MODY: one of the most easily missed causes of diabetes
Morris, J., & Morris, D. (2019) · Journal of Prescribing Practice · doi:10.12968/jprp.2019.1.sup3.s15
Al-Kraity, W. R. H. (2020) · Medical Science Journal for Advance Research · doi:10.46966/msjar.v1i01.5
Endokrinologische Indikationen zur Gendiagnostik
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Wurm, S. (2012) · Springer eBooks · doi:10.1007/978-3-642-29690-1_15
Prediction, diagnosis, prevention and treatment: genetic-led care of patients with diabetes
Tangjittipokin, W., Borrisut, N., & Rujirawan, P. (2021) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1970526
“However, genetic testing plays a crucial role in the diagnosis of monogenic diabetes – both neonatal diabetes and maturity-onset diabetes of the young (MODY).”
BackgroundInfluentialHow to Screen Appropriately for Monogenic Diabetes
Vella, A. V. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch5
Zammitt, N. N., & Frier, B. M. (2015) · Springer eBooks · doi:10.1007/978-1-4471-2789-5_17
Carbohydrate metabolism, diabetes, and hypoglycemia
Dasgupta, A., & Wahed, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815960-6.00009-1 · Cited by 1
Current Perspectives in MODY Management—A Narrative Review
Deteșan, O., Custură, L. M., Kovács, B. I., Schmiedt, R. A., & Tilinca, M. C. (2021) · Timişoara Medical Journal · doi:10.35995/tmj20210204
Monogenic Forms of Diabetes Resulting from Beta-Cell Dysfunction
Hattersley, A. T., Patel, K., & Besser, R. E. J. (2022) · doi:10.1093/med/9780198870197.003.0268
Self-citation(2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832a7e09
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328329fcc2
Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Kleinberger, J. W., Brown, K. M., Silver, K. D., & Shuldiner, A. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_10
Brown, Z. A., & Chang, J. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00010-3 · Cited by 2
Monogenic disorders of the β cell
Chakera, A. J., & Hattersley, A. T. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch28
Self-citationMonogenic forms of diabetes resulting from β cell dysfunction
Besser, R. E. J., & Hattersley, A. T. (2011) · doi:10.1093/med/9780199235292.003.1348
Self-citationGenetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Kleinberger, J. W., Brown, K. M., Silver, K. D., & Shuldiner, A. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_10-2
Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Kleinberger, J. W., Shuldiner, A. R., & Silver, K. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_10-1
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00936-y
Vounzoulaki, E., & Tan, B. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_2 · Cited by 1
Complications Acute and Chronic
Marigliano, M., Sabbion, A., Contreas, G., & Maffeis, C. (2023) · Springer eBooks · doi:10.1007/978-3-031-07008-2_9
Danda, V. S. R., Devireddy, S. R., Paidipally, S. R., Lodha, P., & Kyatham, V. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01245-w
Diagnostic pitfalls in a young adult with new diabetes
Below, N., Morrison, D., McGowan, R., & Jones, G. C. (2023) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0024
Rusyaeva, N. V., Иванович, Г. И., Кононенко, И. В., Nikonova, T. V., & Shestakova, M. V. (2023) · Diabetes Mellitus · doi:10.14341/dm13070 · Cited by 2
Prasad, R. B. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch12
Maturity Onset Diabetes of the Young of eleven Chinese ChildrenPreprint
Ma, S., Li, R., Liu, X., Han, X., Sheng, S., Li, Y., & Zheng, R. (2024) · Research Square · doi:10.21203/rs.3.rs-3893249/v1
Endokrinologische Indikationen zur Gendiagnostik
Schäffler, A., Aslanidis, C., & Dietmaier, W. (2024) · Springer eBooks · doi:10.1007/978-3-662-68563-1_15
Moldovan, R. A., Hidalgo, M. R., Castañé, H., Jiménez-Franco, A., Joven, J., Burks, D. J., Galán, A., & Garcia‐García, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.18.613678
“Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels due to insulin resistance or insulin absence [1].”
BackgroundBuschur, E., & Dungan, K. M. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.case10
1: Monogenic Diabetes: Maturity-Onset Diabetes of the Young (MODY) and Neonatal Diabetes
Naylor, R. N., Greeley, S. A. W., Carmody, D., Hwang, J., Sanyoura, M., Letourneau, L. R., Bell, G. I., & Philipson, L. H. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.01
An Unusual Clinical Presentation of Diabetes Eventually Diagnosed as a Monogenic Form
Montes, V., Chait, A., & Taplin, C. E. (2015) · American Diabetes Association eBooks · doi:10.2337/9781580405713.case3
Endocrinological Indications for Genetic Diagnostics
Schäffler, A., Aslanidis, C., & Dietmaier, W. (2024) · Springer eBooks · doi:10.1007/978-3-662-70260-4_15
(2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.parti-i
Pirimoglu, M. B., Öğütlü, Ö. B. G., Nursoy, H., Önay, H., Sağ, Ş. Ö., Temel, Ş. G., & Eren, E. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04020-4
“Mutations in HNF1A show a high penetrance, so 63% of mutation carriers develop diabetes before 25 years of age [32].”
Tentolouris, N., & Tzeravini, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00275-2
From host genome to the gut microbiome: an Indian lens on the global diabetes genomics landscape
Arjun, S., & Mohan, V. (2025) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-025-00565-1
“MODY comprises a group of monogenic disorders caused by highly penetrant mutations with autosomal dominant inheritance and early onset (Murphy et al. 2008).”
Understanding the Connection Between Diabetes and Cancer
Sekar, P. K. C., & Veerabathiran, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-5651-9_2
Lenin, A., & Rajayan, J. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1871527
Diabetes Mellitus: Review of the Common, Rare, and Uncommon (Conceptual and Metaphorical) Types
Pliszka, M., & Szablewski, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219611
Prediabetes Genes in Pima and Amish
Baier, L. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_5
Bhattacharya, N., Basu, N., Banerjee, S. K., & Malakar, D. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6542-2_28
Metadata
- Authors
- Murphy, R., Ellard, S., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- Corresponding author
- Hattersley, Andrew T
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-02-26
- Volume
- 4
- Issue
- 4
- Pages
- 200-213
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W1996549380
- Semantic Scholar
- ca1487d43edc4a5abbe40904a2e6414a4534638e
- Cited by
- 502
- References
- 91
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 10 · 2023: 18 · 2022: 17 · 2021: 33 · 2020: 23 · 2019: 21 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 33 · 2014: 36 · 2013: 29 · 2012: 42
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- monogenic diabetes, maturity-onset diabetes of the young, neonatal diabetes, molecular genetic classification, Kir6.2, SUR1, sulfonylurea therapy, glucokinase mutations, HNF1A, HNF4α, HNF1B, genetic counseling, insulin therapy
- MeSH terms
- Kcnj11 Channel, Diabetes Mellitus, Diagnosis, Differential, Female, Glucokinase, Humans, Infant, Newborn, Male, Mutation, Receptors, Drug, Potassium Channels, ATP-Binding Cassette Transporters, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4, Sulfonylurea Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.